Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 194,990,877
- Total 13F shares
- 34,211,265
- Share change
- +2,687,151
- Total reported value
- $172,779,991
- Put/Call ratio
- 6.2%
- Price per share
- $5.05
- Number of holders
- 50
- Value change
- +$12,813,644
- Number of buys
- 30
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03879J100:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| QVT Financial LP |
13F
|
Company |
8.2%
|
16,013,540
|
$99,284,000 | — | 30 Sep 2017 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.7%
|
5,266,280
|
$32,651,000 | — | 30 Sep 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
3,990,400
|
$24,740,000 | — | 30 Sep 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.91%
|
1,768,891
|
$13,349,000 | — | 30 Sep 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.9%
|
1,754,105
|
$10,875,000 | — | 30 Sep 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.44%
|
853,929
|
$5,294,000 | — | 30 Sep 2017 | |
| AXA S.A. |
13F
|
Company |
0.3%
|
575,268
|
$3,567,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
421,601
|
$2,614,000 | — | 30 Sep 2017 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.13%
|
250,015
|
$1,550,000 | — | 30 Sep 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.12%
|
224,655
|
$1,393,000 | — | 30 Sep 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.09%
|
180,582
|
$1,120,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.09%
|
176,091
|
$1,092,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
160,610
|
$996,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
131,000
|
$811,000 | — | 30 Sep 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.07%
|
129,260
|
$801,000 | — | 30 Sep 2017 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.06%
|
124,273
|
$778,000 | — | 30 Sep 2017 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.06%
|
125,000
|
$775,000 | — | 30 Sep 2017 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
118,000
|
$732,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.06%
|
112,927
|
$700,000 | — | 30 Sep 2017 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.06%
|
110,000
|
$682,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.04%
|
78,634
|
$488,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
75,741
|
$470,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
52,566
|
$326,000 | — | 30 Sep 2017 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$247,000 | — | 30 Sep 2017 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.02%
|
31,650
|
$196,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
27,115
|
$168,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
22,520
|
$140,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
20,046
|
$124,000 | — | 30 Sep 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
19,830
|
$123,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
0.01%
|
19,200
|
$119,000 | — | 30 Sep 2017 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.01%
|
16,882
|
$104,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
13,151
|
$84,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
13,281
|
$83,000 | — | 30 Sep 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
12,996
|
$81,000 | — | 30 Sep 2017 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
12,605
|
$78,000 | — | 30 Sep 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
11,600
|
$71,000 | — | 30 Sep 2017 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
10,983
|
$68,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
10,355
|
$64,000 | — | 30 Sep 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
10,300
|
$64,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
9,738
|
$60,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
8,283
|
$51,000 | — | 30 Sep 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
3,400
|
$21,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3,400
|
$21,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,950
|
$12,000 | — | 30 Sep 2017 | |
| Cutler Group LLC / CA |
13F
|
Company |
0%
|
1,400
|
$8,000 | — | 30 Sep 2017 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
800
|
$4,960 | — | 30 Sep 2017 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
360
|
$2,000 | — | 30 Sep 2017 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
300
|
$2,000 | — | 30 Sep 2017 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2017 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2017
As of 31 Dec 2017,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,211,265 shares.
The largest 10 holders included
QVT Financial LP, RTW INVESTMENTS, LP, PRIMECAP MANAGEMENT CO/CA/, LADENBURG THALMANN FINANCIAL SERVICES INC., D. E. Shaw & Co., Inc., BANK OF MONTREAL /CAN/, BlackRock Inc., MORGAN STANLEY, AXA, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
51
Q4 2017 holders
50
Holder diff
-1
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.